United Bank (West Virginia)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$493K Hold
3,386
0.2% 62
2017
Q2
$440K Buy
3,386
+740
+28% +$90.7K 0.19% 65
2017
Q1
$329K Hold
2,646
0.14% 86
2016
Q4
$306K Buy
2,646
+396
+18% +$44.1K 0.14% 91
2016
Q3
$235K Hold
2,250
0.11% 97
2016
Q2
$222K Hold
2,250
0.1% 92
2016
Q1
$225K Hold
2,250
0.1% 100
2015
Q4
$269K Hold
2,250
0.13% 85
2015
Q3
$243K Hold
2,250
0.13% 88
2015
Q2
$260K Sell
2,250
-750
-25% -$85.7K 0.12% 90
2015
Q1
$346K Hold
3,000
0.15% 79
2014
Q4
$336K Hold
3,000
0.12% 80
2014
Q3
$284K Buy
+3,000
New +$271K 0.11% 84
2014
Q2
Sell
-3,000
Closed -$209K 122
2014
Q1
$209K Hold
3,000
0.08% 110
2013
Q4
$253K Hold
3,000
0.1% 103
2013
Q3
$231K Buy
+3,000
New +$210K 0.1% 101

Other funds holding CELG

United Bank (West Virginia)'s CELG Position: Q3 2017 in Review

United Bank (West Virginia) held its Celgene Corp (CELG) position steady in Q3 2017 at 3,386 shares worth $493K. The position accounts for 0.2% of the portfolio, ranked #62.

United Bank (West Virginia) first reported a position in CELG in Q3 2013 and has held it in 16 quarters since. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • United Bank (West Virginia) held 3,386 shares of Celgene Corp worth $493K as of Q3 2017.
  • United Bank (West Virginia) left its Celgene Corp share count unchanged in Q3 2017.
  • Celgene Corp made up 0.2% of United Bank (West Virginia)'s portfolio in Q3 2017, its #62 holding.
  • United Bank (West Virginia) first reported a position in Celgene Corp in Q3 2013 and has held it in 16 quarters since.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on United Bank (West Virginia)'s 13F filing for Q3 2017, filed 26 Oct 2017.